Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 80880W205 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
| SCLX Stock Acquisition JV LLC 13D/A Amendment 6 | 11.4% |
7/7/2026
Event 7/3/2026
|
|
| Oramed Pharmaceuticals Inc. 13G/A Amendment 4 | 4.9% |
2/13/2026
Event 12/31/2025
|
|
| Oramed Pharmaceuticals Inc. 13G/A Amendment 3 | 9.9% |
11/14/2025
Event 9/30/2025
|
|
| Oramed Pharmaceuticals Inc. 13G/A Amendment 2 | 9.9% |
8/14/2025
Event 6/30/2025
|
|
|
Armistice Capital, LLC
13G/A
Amendment 5
|
8.7% |
8/14/2025
Event 6/30/2025
|
|
| Armistice Capital, LLC | 8.7% | ||
| Steven Boyd | 8.7% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 6 | 41.0 | $178.00 |
| 2026 Q2 | 73 | 703 k | $5.48 M |
| 2026 Q1 | 73 | 872 k | $5.81 M |
| 2025 Q4 | 82 | 1.12 M | $13.7 M |
| 2025 Q3 | 85 | 760 k | $15.0 M |
| 2025 Q2 | 72 | 633 k | $3.73 M |
| 2025 Q1 | 6 | 478 k | $118 k |
| 2024 Q4 | 1 | 19.0 | $8.00 |
| 2024 Q3 | 1 | 19.0 | $18.00 |
| 2024 Q2 | 1 | 19.0 | $37.00 |